[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-340362-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-340362-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","2d-differential-metallic-immunopotentiators-drive-high-diversity-and-capability-of-antigen-specific-immunity-against-tumor","2D Differential Metallic Immunopotentiators Drive High Diversity and Capability of Antigen-specific Immunity Against Tumor","","Therapeutic cancer vaccines in clinic still show limited efficacy. A rationally designed vaccine places immunogenically differentiated, clinically approved aluminum (Al) or manganese (Mn) into a 2D nanosheet architecture with antigens. The structurally optimized nanosheets with high Mn/Al molar ratio drive strong innate immune cell infiltration and multi-subset dendritic cell activation, boosting antigen-specific T cell levels, subtypes, and functions. They outperform Alhydrogel for antibody generation and also induce Th1 and CD8+ responses, promoting tumor regression in aggressive models.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/2d-differential-metallic-immunopotentiators-drive-high-diversity-and-capability-of-antigen-specific-immunity-against-tumor/340362/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/2d-differential-metallic-immunopotentiators-drive-high-diversity-and-capability-of-antigen-specific-immunity-against-tumor/340362.png","ImageObject",300,407,{"name":42,"@type":43},"Eden","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",16,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main strategy of the reported cancer vaccine design?","Question",{"text":63,"@type":64},"It integrates immunogenically differentiated aluminum or manganese into a 2D nanosheet architecture together with antigens to enhance antigen-specific immunity.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does the 2D nanosheet design influence the innate immune response?",{"text":68,"@type":64},"Structurally optimal nanosheets with a high Mn to Al molar ratio promote the influx of heterogeneous innate immune cells and stimulate multiple dendritic cell subsets at the injection site.",{"name":70,"@type":61,"acceptedAnswer":71},"How does the vaccine performance compare with the commercial adjuvant Alhydrogel?",{"text":72,"@type":64},"The high Mn/Al nanosheet formulation generates even more effective antigen-specific antibodies than Alhydrogel by priming Th2 cells rather than T follicular helper cells, and it also elicits strong Th1 and CD8+ immunity.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},340362,1790129960,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":118,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":104,"preview_page_count":33,"preview_urls":145},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","RESEARCH ARTICLE  \n[www.advancedscience.com](www.advancedscience.com)  \n2D Diﬀerential Metallic Immunopotentiators Drive High Diversity and Capability of Antigen-speciﬁc Immunity Against Tumor  \nHongze Ren, Anqi Zhu, Wei Yang, Yiwen Jia, Hui Cheng, Ye Wu, Zhengqi Tang, Weifan Ye, Mayu Sun, Yujie Xie,* Meihua Yu,* and Yu Chen*  \nThe therapeutic eﬃcacy of vaccines for treating cancers in clinics remains limited. Here, a rationally designed cancer vaccine by placing immunogenically diﬀerential and clinically approved aluminum (Al) or manganese (Mn) in a 2D nanosheet (NS) architecture together with antigens is reported. Structurally optimal NS with a high molar ratio of Mn to Al (MANS-H) features distinctive immune modulation, markedly promoting the inﬂux of heterogeneous innate immune cells at the injection site. Stimulation of multiple subsets of dendritic cells (DCs) signiﬁcantly increases the levels, subtypes, and functionalities of antigen-speciﬁc T cells. MANS-H demonstrates even greater eﬀectiveness in the production of antigen-speciﬁc antibodies than the commercial adjuvant (Alhydrogel) by priming T helper (Th)2 cells rather than T follicular helper (Tfh) cells. Beyond humoral immunity, MANS-H evokes high frequencies of antigen-speciﬁc Th1 and CD8+ cell immunity, which are comparable with Quil-A that is widely used in veterinary vaccines. Immunized mice with MANS-H adjuvanted vaccines exert strong potency in tumor regression by promoting eﬀector T cells inﬁltrating at tumor and overcoming tumor resistance in multiple highly aggressive tumor models. The engineered immunogen with an intriguing NS architecture and safe immunopotentiators oﬀers the next clinical advance in cancer immunotherapy.  \n1. Introduction  \nBreakthrough development of new vaccines could save millions of lives, of which adjuvants are essential ingredients in vaccine formulations, harnessing the host immune response against antigens with remarkably enhanced magnitude, longevity, andeﬀectiveness. [1] Despite over 100 years old history of the use of adjuvants (e.g., aluminum salts ﬁrst used in 1926) in human vaccines, only a few adjuvants have been approved in licensed vaccines in clinics to date. [2] Numerous innovative adjuvant platforms containing distinct immunostimulants are undergoing explosive exploration to complement the classical adjuvants that hardly trigger an appropriate immune response against a broad spectrum of diseases that are problematic to be prevented or cured, such as cancer, HIV (human immunodeﬁciency virus), and malaria. [1,3] The understanding of the mechanism of action of adjuvants is of great interest, forming the foundation for advances in adjuvant development and vaccinology. Aluminumcontaining adjuvants are known to produce  \nH. Ren, Y. Jia, H. Cheng, Y. Wu, Z. Tang, W. Ye, Y. Xie, M. Yu, Y. Chen  \nMaterdicine Lab School of Life Sciences Shanghai University Shanghai 200444, China  \nE-mail: [xieyj@shu.edu.cn](xieyj@shu.edu.cn); [myu@shu.edu.cn](myu@shu.edu.cn); [chenyuedu@shu.edu.cn](chenyuedu@shu.edu.cn)  \nH. Ren, Y. Wu, Y. Xie, Y. Chen School of medicine Shanghai University Shanghai 200444, China  \nThe ORCID identiﬁcation number(s) for the author(s) of this article  \ncan be found under [https://doi.org/10.1002/advs.202405729](https://doi.org/10.1002/advs.202405729)[ ](https://doi.org/10.1002/advs.202405729)© 2024 The Author(s). Advanced Science published by Wiley-VCH GmbH. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \nDOI: 10.1002/advs.202405729  \nA. Zhu  \nDepartment of Medical Ultrasound Shanghai Tenth People’s Hospital  \nSchool of Medicine Tongji University Shanghai 200070, China  \nW. Yang  \nDepartment of Urology Xinhua Hospital  \nSchool of Medicine Shanghai Jiaotong University  \nShanghai 200092, China  \nM. Sun  \nLaboratory Center  \nShanghai Municipal Hospital of Tradit","cbCaignfWNP4Pa79","https://ap.wps.com/l/cbCaignfWNP4Pa79","pdf",8651281,"English","# Introduction\n## Adjuvants and limitations in cancer vaccination\n## Immunomodulatory roles of aluminum-based adjuvants\n## Mechanisms and evidence for manganese-driven immune sensing","[{\"question\":\"What is the main strategy of the reported cancer vaccine design?\",\"answer\":\"It integrates immunogenically differentiated aluminum or manganese into a 2D nanosheet architecture together with antigens to enhance antigen-specific immunity.\"},{\"question\":\"How does the 2D nanosheet design influence the innate immune response?\",\"answer\":\"Structurally optimal nanosheets with a high Mn to Al molar ratio promote the influx of heterogeneous innate immune cells and stimulate multiple dendritic cell subsets at the injection site.\"},{\"question\":\"How does the vaccine performance compare with the commercial adjuvant Alhydrogel?\",\"answer\":\"The high Mn/Al nanosheet formulation generates even more effective antigen-specific antibodies than Alhydrogel by priming Th2 cells rather than T follicular helper cells, and it also elicits strong Th1 and CD8+ immunity.\"}]","2D Differential Metallic Immunopotentiators Drive High Diversity and Capability of Antigen-specific Immunity Against Tumor | PDF",1790036017,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fe04f39e7ebe9ad0699d8eb7af43230d.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/289065e6de1910237002f0efe6f3ed56.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0ab543888acfa30d2593d00a8e0f0825.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/046fe54642b39849343af93f5eda8e7f.webp",980,1287]